Literature DB >> 26611607

The accuracy and timeliness of neuraminidase inhibitor dispensing data for predicting laboratory-confirmed influenza.

J Papenburg1, K M Charland2, G DE Serres3, D L Buckeridge1.   

Abstract

Neuraminidase inhibitor (NI) dispensing has emerged as a possible automated data source for influenza surveillance. We aimed to evaluate its timeliness, correlation, and predictive accuracy in relation to influenza activity in Quebec, Canada, 2010-2013. Our secondary objective was to use the same metrics to compare NI dispensing to visits for influenza-like illness (ILI) in emergency departments (EDs). Provincial weekly counts of positive influenza laboratory tests were used as a reference measure for the level of influenza circulation. We applied ARIMA models to account for serial correlation. We computed cross-correlations to measure the strengths of association and lead-lag relationships between NI dispensing, ILI ED visits, and our reference indicator. Finally, using an ARIMA model, we evaluated the ability of NI dispensing and ILI ED visits to predict laboratory-confirmed influenza. NI dispensing was significantly correlated (R = 0·68) with influenza activity with no lag. The maximal correlation of ILI ED visits was not as strong (R = 0·50). Both NI dispensing and ILI ED visits were significant predictors of laboratory-confirmed influenza in a multivariable model; predictive potential was greatest when NI counts were lagged to precede laboratory surveillance by 2 weeks. We conclude that NI dispensing data provides timely and valuable information for influenza surveillance.

Entities:  

Keywords:  Antiviral drugs; community pharmacies; influenza; multivariate analysis; public health surveillance

Mesh:

Substances:

Year:  2015        PMID: 26611607      PMCID: PMC9150702          DOI: 10.1017/S095026881500299X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  32 in total

1.  The run on tamiflu--should physicians prescribe on demand?

Authors:  Allan S Brett; Abigail Zuger
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Timeliness of data sources used for influenza surveillance.

Authors:  Lynne Dailey; Rochelle E Watkins; Aileen J Plant
Journal:  J Am Med Inform Assoc       Date:  2007-06-28       Impact factor: 4.497

3.  Timely detection of localized excess influenza activity in Northern California across patient care, prescription, and laboratory data.

Authors:  Sharon K Greene; Martin Kulldorff; Jie Huang; Richard J Brand; Kenneth P Kleinman; John Hsu; Richard Platt
Journal:  Stat Med       Date:  2011-02-28       Impact factor: 2.373

4.  Outpatient physician billing data for age and setting specific syndromic surveillance of influenza-like illnesses.

Authors:  Emily H Chan; Robyn Tamblyn; Katia M L Charland; David L Buckeridge
Journal:  J Biomed Inform       Date:  2010-10-15       Impact factor: 6.317

5.  Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study.

Authors:  M C Zambon; J D Stockton; J P Clewley; D M Fleming
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

6.  Evaluation of syndromic surveillance in the Netherlands: its added value and recommendations for implementation.

Authors:  C C van den Wijngaard; W van Pelt; N J Nagelkerke; M Kretzschmar; M P Koopmans
Journal:  Euro Surveill       Date:  2011-03-03

7.  Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

8.  The need for validation of statistical methods for estimating respiratory virus-attributable hospitalization.

Authors:  Rodica Gilca; Gaston De Serres; Danuta Skowronski; Guy Boivin; David L Buckeridge
Journal:  Am J Epidemiol       Date:  2009-08-13       Impact factor: 4.897

9.  Syndromic surveillance for influenzalike illness in ambulatory care network.

Authors:  Benjamin Miller; Heidi Kassenborg; William Dunsmuir; Jayne Griffith; Mansour Hadidi; James D Nordin; Richard Danila
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

10.  Adherence to oseltamivir guidelines during influenza pandemic, the Netherlands.

Authors:  Esther H Fietjé; Daphne Philbert; Erica C G van Geffen; Nina A Winters; Marcel L Bouvy
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883

View more
  1 in total

1.  Time-series analysis of tuberculosis from 2005 to 2017 in China.

Authors:  H Wang; C W Tian; W M Wang; X M Luo
Journal:  Epidemiol Infect       Date:  2018-04-30       Impact factor: 4.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.